Medicine and Dentistry
Myeloproliferative Neoplasm
80%
Pulmonary Hypertension
20%
Mucormycosis
20%
Hydroxyurea
20%
DNA Methyltransferase 3A
20%
Severe Acute Respiratory Syndrome
20%
Interferon
20%
Lymphoma
20%
Interferon Alfa
20%
Febrile Neutropenia
20%
Antifungal Therapy
20%
Diagnosis
20%
Case-Control Study
20%
Glycon
20%
Malignant Neoplasm
18%
Infection
17%
Polymerase Chain Reaction
16%
Janus Kinase
15%
Posaconazole
12%
Debridement
12%
Population
10%
Odds Ratio
10%
Next Generation Sequencing
10%
Gene Frequency
10%
Isavuconazole
8%
Amphotericin B
8%
Monotherapy
8%
Biopsy
8%
Antifungal Agent
8%
Surgical Margin
8%
Hospital Infection
6%
Hematological Cancer
5%
Cancer Risk
5%
Neoplasm
5%
Apoplexy
5%
ASXL1
5%
Clinical Trial
5%
Recombinant Alpha Interferon
5%
Low Drug Dose
5%
Somatic Mutation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Myeloproliferative Neoplasm
100%
Case-Control Study
40%
Malignant Neoplasm
30%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
DNA Methyltransferase 3A
20%
Febrile Neutropenia
20%
Pulmonary Hypertension
20%
Severe Acute Respiratory Syndrome
20%
Hydroxycarbamide
20%
Interferon
20%
Alpha Interferon
20%
Lymphoma
20%
Metformin
20%
Janus Kinase
15%
Statin (Protein)
12%
Infection
9%
Neoplasm
6%
Hospital Infection
6%
Recombinant Alpha Interferon
5%
Alpha1 Interferon
5%
Clinical Trial
5%
Biochemistry, Genetics and Molecular Biology
Case-Control Study
40%
Population
30%
Hydroxycarbamide
20%
Interferon
20%
interferon
20%
Blood Cell Count
20%
Statin
20%
Population Research
12%
Myeloid
11%
DNMT3A
11%
Dose Response
10%
Janus Kinase
8%
Cancer Incidence
6%
Next Generation Sequencing
5%
Gene Frequency
5%
